Expert's Opinion

Smoother Sailing in Skin Care?

October 18, 2010

Dr. Ranella Hirsch of Vichy Laboratories details the latest breakthrough in cellulite treatments.

By Dr. Ranella Hirsch

An estimated 90% of the female population is affected by cellulite in varying severity depending on weight, nationality and skin elasticity. Although exercise and a balanced diet are clinically proven to help maintain a healthy weight, these can only do so much to prevent this stubborn problem, which affects women of all shapes and sizes.

While even liposuction or dieting cannot completely remove cellulite, Vichy Laboratoires has made a breakthrough with CelluDestock, a topical cream formulated to accelerate cellulite reduction for a visible loss of up to one cellulite grade in four weeks. Paraben-free CelluDestock is the first topical slimming accelerator on the market, and is the No. 1 selling cellulite cream in Canada and No. 2 in Europe,according to Vichy Laboratories.

Women are more predisposed to the appearance of cellulite due to the vertical nature of the fibrous bands binding the fat, which is in contrast to the more net-like appearance of the bands found in men. Also, since women generally have thinner skin than men, we more commonly encounter this frustration among women. Indeed, cellulite remains among the biggest complaints I receive from women on a daily basis. They tell me that what they find particularly frustrating is that no amount of gym time seems to get rid of the bumps. The hips, thighs, and buttocks are most prone to cellulite. These areas are where women have a propensity to carry weight gain and are also more resistant to weight loss from dieting.

Scientists at Vichy Laboratoires have conducted years of research on this prevalent problem, and have found there are three types of the cellulite troubling women. Most women acquire at least two cellulite types:

Fibrous cellulite: collagen fibers stiffen, compressing fat cells and compromising micro-circulation. This is the most advanced type of cellulite.

Aqueous cellulite: Water retention due to poor blood circulation. Water accumulates between fat cells, which become more visible.

Adipose cellulite: Excess fat tissue as a result of adipocytes (individual fat cells) swelling anywhere from 30-120x their size.

To combat all types of cellulite on these diet-resistant areas, Vichy Laboratoires harnessed the power of two key ingredients: Pure Caffiene 5% and Lipocidine to form CelluDestock. Lipocidine is an active ingredient scientifically proven to help stimulate the expression of a protein that promotes the breakdown of excess lipids stocked in adipose (fat) tissue. Pure Caffeine 5% reinforces the action of Lipocidine. It is known for its ability to activate the breakdown of fats and helps to promote micro-circulation. This active slimming ingredient works at the pharmaceutical concentration of 5%.

In a study Vichy Laboratories conducted on 50 women, skin texture was smoother on stomach, thighs and buttocks in seven days, reducing the orange peel like appearance. In two weeks, skin was firmer and more elastic. In four weeks, cellulite was visibly reduced by up to 1 cellulite grade. Skin on the thighs and buttocks appeared more defined. In addition, the breakdown of excess volume was improved by 80%, even on areas predisposed to stubborn fat: hips, thighs, and buttocks. Forty-nine out of 50 also saw a reduction in the appearance of cellulite on pinching, and all 50 saw a loss in hip, thigh and buttock volume.

More info:

About the author
Board certified dermatologist Dr. Ranella Hirsch is a frequently quoted expert in the fields of cosmetic and laser dermatology. She is the senior medical advisor for Vichy Laboratories, a division of L’Oreal Paris, a scientific board advisor to Unilever and a principal of several laser technology and new media startups. Currently, she is working on several clinical trials for topical skin care products to improve the condition and appearance of aging skin and her innovative research continues to develop and foster new cosmetic dermatology technologies and techniques. Hirsch is also currently on faculty at the Boston University School of Medicine.

Related End-User Markets:

Related Raw Materials: